Pharmafile Logo
Pharmafocus logo
Advanced Search

Vaccine

Showing 15 posts of 284 posts found.

seqirus_08-11-17_full-42_003_web

Seqirus announces £40m UK fill-and-finish flu vaccine facility

November 9, 2017
Manufacturing and Production Liverppol, Novartis, UK, Vaccine, flu, influenza, pharma, seqirus

Seqirus, an influenza vaccine specialist subsidiary of global biotech firm CSL, has announced a £40 million investment into a new …

News
lilly_entrance_web

Lilly teams up with CureVac in $1.8 billion cancer vaccine partnership

October 19, 2017
Research and Development, Sales and Marketing Cancer, CureVac, Eli Lilly, Vaccine

Eli Lilly has announced it is to partner up with CureVac to leverage its proprietary RNActive technology in order to …

News
flu_vaccine

‘Universal flu vaccine’ to be trialed this winter

October 3, 2017
Manufacturing and Production, Medical Communications Flu virus, Vaccine, biotech, drugs, influenza, pharma, pharmaceutical

Researchers are enrolling 500 participants for the trial of a flu vaccine to protect the population against all strains of …

News

Sanofi backs out of controversial Zika vaccine project

September 4, 2017
Research and Development, Sales and Marketing Sanofi, US, Vaccine, Zika, biotech, drugs, pharma, pharmaceutical

Sanofi’s development of a Zika vaccine, alongside the US’s Biomedical Advanced Research and Development Authority (BARDA), has hit the headlines …

News
vaccine

Reversal of type 1 diabetes possible through century-old vaccine

June 14, 2017
Research and Development BCG, Type 1 diabetes, Vaccine, diabetes

The American Diabetes Association 77th Scientific Sessions closed yesterday and one of the most interesting pieces of research to emerge …

News
hiv

Inovio posts “exceptional” results for HIV vaccine

May 25, 2017
Research and Development AIDS, HIV, HIV vaccine, Vaccine

Inovio Pharmaceuticals has been working on HIV vaccines for a long time and, eight years after signing a $25 million …

News
aedes_aegypti_mosquito

Brazil declares end to Zika virus emergency

May 12, 2017
Medical Communications Brazil, Vaccine, Zika, Zika virus

Brazil has declared that the national emergency over the Zika virus threat is over, after there was a 95% drop …

News
mosquito

Malaria vaccine displays 100% success rate in clinical trial

February 16, 2017
Research and Development Vaccine, malaria

A malaria vaccine, jointly developed by the University of Tübingen and biotech company Sanaria Inc., has demonstrated in a small pool …

News
immunisation

African Heads of State commit to universal access to immunisation

February 1, 2017
Medical Communications, Research and Development Africa, Vaccine, WHO, immunisation

The Heads of State convened from across Africa to ratify the Addis Declaration on Immunization (ADI). The pledge commits to …

News
dengue_mosquito_web

Philippine FDA orders Sanofi to pull dengue vaccine ads

January 5, 2017
Medical Communications, Sales and Marketing Philippines, Sanofi, Vaccine, dengue, virus

Sanofi has suffered a major blow to its dengue immunisation programme in the Philippines after it was requested the company …

News
cuba_us_flags

FDA approves clinical trial of Cuban lung cancer vaccine

November 1, 2016
Manufacturing and Production, Sales and Marketing Cuba, US, Vaccine, cimavax, clinical trials

The thawing of relations between the US and Cuba has allowed a pioneering treatment for non-small cell lung cancer to …

News
gsk_boronia_australia

GSK applies for FDA approval for shingles vaccine

October 24, 2016
Sales and Marketing GSK, GlaxoSmithKline, Vaccine, chickenpox, shingles

GlaxoSmithKlien, the UK’s biggest drugmaker, is seeking approval from the FDA for a shingles (herpes zoster) vaccine. The vaccine would …

News
vaccine3a-062568e

Sun Pharma partners with ICGEB to develop dengue vaccine

October 19, 2016
Research and Development Vaccine, dengue, icgeb, sun pharmaceutical

Indian drug firm Sun Pharma is set to join forces with the International Centre for Generic Engineering and Biotechnology (ICGEB) …

News
hiv-infected_h9_t-cell_-_credit_national_institutes_of_health-web

Kymab demonstrates promising research for HIV vaccine development

September 9, 2016
Medical Communications, Research and Development HIV, Vaccine, kymab

Cambridge-based antibodies-to-medicines company Kymab has announced publication of research testing the first step in the effort to develop effective vaccines …

News
takeda_tokyo_hq

Takeda begins Phase III dengue vaccine trial

September 8, 2016
Research and Development Takeda, Vaccine, dengue, dengue vaccine, phase III, trial

Takeda Pharmaceuticals has announced the initiation of a global Phase III clinical trial to test its live-attenuated tetravalent dengue vaccine …

News

Latest content

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

May 17, 2024

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

May 17, 2024

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024